Cargando…
Evaluation of ceftiofur–PHBV microparticles in rats
Despite the high number of antibiotics used for the treatment of infectious disease in animals, the development of slow release formulations presents a significant challenge, particularly in using novel biomaterials with low cost. In this report, we studied the pharmacokinetics, toxicity, and therap...
Autores principales: | Vilos, Cristian, Constandil, Luis, Rodas, Paula I, Cantin, Mario, Zepeda, Katherine, Herrera, Natalia, Velasquez, Luis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047837/ https://www.ncbi.nlm.nih.gov/pubmed/24936127 http://dx.doi.org/10.2147/DDDT.S60444 |
Ejemplares similares
-
Preclinical Development and In Vivo Efficacy of Ceftiofur-PLGA Microparticles
por: Vilos, Cristian, et al.
Publicado: (2015) -
Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties
por: Solar, Paula, et al.
Publicado: (2015) -
Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
por: Cabaña-Brunod, Mauricio, et al.
Publicado: (2021) -
PCL/PHBV Microparticles as Innovative Carriers for Oral Controlled Release of Manidipine Dihydrochloride
por: Barboza, Fernanda Malaquias, et al.
Publicado: (2014) -
Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines
por: Peñaloza, Juan P., et al.
Publicado: (2017)